Oruka Therapeutics (ORKA) Change in Taxes (2018 - 2019)
Oruka Therapeutics' (ORKA) quarterly Change in Taxes came in at $16000.0 in Q4 2019, down 30.43% year-on-year from $23000.0 in Q4 2018, and down 61.9% quarter-over-quarter from $42000.0 in Q3 2019.
Oruka Therapeutics (ORKA) Change in Taxes (2018 - 2019) Analysis & Trends
Oruka Therapeutics' Change in Taxes history runs 2 years deep, the most recent figure standing at $16000.0 for Q4 2019.
- On a quarterly basis, Change in Taxes fell 30.43% year-over-year to $16000.0 in Q4 2019; TTM through Dec 2020 was $58000.0, a 65.27% decrease from a year earlier, with the FY2020 full-year figure at $9000.0, down 94.61% from the prior year.
- Change in Taxes declined to $16000.0 in Q4 2019 per ORKA's latest filing, from $42000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $82000.0 in Q1 2019 and bottomed at $16000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 16,000.00 |
| Dec 31, 2019 | 16,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Jun 30, 2019 | 27,000.00 |
| Jun 30, 2019 | 27,000.00 |
| Mar 31, 2019 | 82,000.00 |
| Mar 31, 2019 | 82,000.00 |
| Dec 31, 2018 | 23,000.00 |
| Dec 31, 2018 | 23,000.00 |